Companies
Vetter Pharma
PFS & Auto-injectors — Dual-chamber syringe assembly.
- Country
- Germany
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| therapeutics-platforms | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | EUR 47 million in EU-approved state aid for the Saarlouis facility project (2026-06-02) | vetter-pharma.com |
| Capacity | 77.2 million device assembly and packaging units processed in 2025 (2025-12-31) | vetter-pharma.com |
| Certification | ISO 14001, ISO, GMP (2026-09-02) | pharmasource.global |
| Regulatory approval | FDA, EMA, PMDA, Tübingen Regional Council (2026-09-02) | vetter-pharma.com |
| Production site | Ravensburg and Langenargen, Germany; Rankweil, Austria; Des Plaines, USA (Chicago area) (2026-09-02) | ondrugdelivery.com · vetter-pharma.com |
| Headcount | 7,300+ employees worldwide (2026-09-02) | vetter-pharma.com |
| Revenue | EUR 1.26 billion in 2025 sales revenue (2025-12-31) | vetter-pharma.com |
Independent sources: ondrugdelivery.com · pharmasource.global
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Fill-finish & aseptic biomanufacturing | therapeutics-platforms | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.